A factor VIII-polypeptide with factor VIII:C-activity

Details for Australian Patent Application No. 2004222822 (hide)

Owner Stichting Sanquin Bloedvoorziening

Inventors Scheiflinger, Friedrich; Pannekoek, Hans; Van Mourik, Jan Aart; Schwarz, Hans-Peter; Lenting, Petrus Johannes; Mertens, Koenraad; Turecek, Peter

Agent Peter Maxwell & Associates

Pub. Number AU-B-2004222822

Parent 775529

Filing date 22 October 2004

Wipo publication date 18 November 2004

Acceptance publication date 25 January 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/37 (2006.01) Medicinal preparations containing peptides

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 November 2004 Complete Application Filed

18 November 2004 Application Open to Public Inspection

  Published as AU-B-2004222822

2 March 2006 Assignment before Grant

  Baxter Aktiengesellschaft The application has been assigned to Stichting Sanquin Bloedvoorziening

25 January 2007 Application Accepted

  Published as AU-B-2004222822

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222823-Composition, Methods and Reagents for the Synthesis of a Soluble Form of Human PHEX

2004222821-Integrated visualization of security information for an individual